ChristianaCare and Virtua Health Plan to Co-Found New Regional Nonprofit Health System

ChristianaCare and Virtua Health Plan to Co-Found New Regional Nonprofit Health System

ChristianaCare and Virtua Health Plan to Co-Found New Regional Nonprofit Health System ChristianaCare and Virtua Health have signed a non-binding letter of intent (LOI) to explore the co-founding of a regional not-for-profit health system. The combined system would provide care across more than…

Read MoreChristianaCare and Virtua Health Plan to Co-Found New Regional Nonprofit Health System
Hippocratic AI and Sheba Medical Center Join Forces to Revolutionize Patient Care with Generative AI

Hippocratic AI and Sheba Medical Center Join Forces to Revolutionize Patient Care with Generative AI

Hippocratic AI, the global leader and pioneer in generative AI healthcare agents, today announced a partnership with Sheba Medical Center, a global beacon of medical innovation and research ranked by Newsweek as one of the top ten hospitals in the…

Read MoreHippocratic AI and Sheba Medical Center Join Forces to Revolutionize Patient Care with Generative AI
Netsmart and Oregon Council Partner to Advance Value-Based Behavioral Health Tech Statewide

Netsmart and Oregon Council Partner to Advance Value-Based Behavioral Health Tech Statewide

Netsmart and the Oregon Council for Behavioral Health (OCBH), a statewide nonprofit association dedicated to ensuring access to quality treatment and care, announced a new program aimed at enhancing behavioral health services through innovative technology across Oregon. Through the OCBH Preferred…

Read MoreNetsmart and Oregon Council Partner to Advance Value-Based Behavioral Health Tech Statewide
Spear Bio Forms Strategic Partnership with Bio-Techne to Advance Next-Generation Immunoassay Technology Deployment

Spear Bio Forms Strategic Partnership with Bio-Techne to Advance Next-Generation Immunoassay Technology Deployment

Spear Bio, a biotechnology company pioneering homogeneous ultrasensitive immunoassay technology, is pleased to announce a strategic distribution partnership with Bio-Techne Corporation (NASDAQ: TECH), a global leading provider of innovative reagents, instruments, and solutions for life-science research and clinical diagnostics. The…

Read MoreSpear Bio Forms Strategic Partnership with Bio-Techne to Advance Next-Generation Immunoassay Technology Deployment
Radiology Partners Launches Mosaic Clinical Technologies™ and MosaicOS™

Radiology Partners Launches Mosaic Clinical Technologies™ and MosaicOS™

 The leading provider of technology-enabled radiology services in the U.S., announced today the launch of its new technology services division, Mosaic Clinical Technologies™ and MosaicOS™ a proprietary, radiologist-driven platform designed to address emergent challenges facing the specialty, including rising imaging…

Read MoreRadiology Partners Launches Mosaic Clinical Technologies™ and MosaicOS™
BioAffinity Technologies Receives China Patent for Its Noninvasive Lung Cancer Diagnostic Tool

BioAffinity Technologies Receives China Patent for Its Noninvasive Lung Cancer Diagnostic Tool

BioAffinity Technologies Receives China Patent for Its Noninvasive Lung Cancer Diagnostic Tool A biotechnology company advancing early-stage cancer diagnostics including CyPath® Lung, the Company’s commercially available test for early-stage lung cancer, today announced it has received notification of allowance from the…

Read MoreBioAffinity Technologies Receives China Patent for Its Noninvasive Lung Cancer Diagnostic Tool
Proximie Partners with U.S. MedTech Leader Imperative Care to Advance Robotic Stroke Treatment System

Proximie Partners with U.S. MedTech Leader Imperative Care to Advance Robotic Stroke Treatment System

The leading global health technology platform digitising operating rooms (“OR”), announces a partnership with U.S.-based medical technology company, Imperative Care – with the aim of driving the development of a robotic surgical system to treat ischemic stroke. Imperative Care researches, develops and…

Read MoreProximie Partners with U.S. MedTech Leader Imperative Care to Advance Robotic Stroke Treatment System
Varian Launches IntelliBlate in Europe, Enhancing Image-Guided Cancer Treatment with Integrated Microwave Ablation Technology

Varian Launches IntelliBlate in Europe, Enhancing Image-Guided Cancer Treatment with Integrated Microwave Ablation Technology

Varian, a Siemens Healthineers company, today announced the European launch of IntelliBlate, its next generation microwave ablation solution, for the treatment of soft tissue tumors. Now CE-marked, IntelliBlate represents a pivotal milestone in expanding access to an integrated, intuitive, and…

Read MoreVarian Launches IntelliBlate in Europe, Enhancing Image-Guided Cancer Treatment with Integrated Microwave Ablation Technology
Aviva Biopharm Reveals Promising Preclinical Results for d3-T, a First-in-Class Women's Testosterone Therapy, at ENDO 2025

Aviva Biopharm Reveals Promising Preclinical Results for d3-T, a First-in-Class Women’s Testosterone Therapy, at ENDO 2025

Aviva Biopharm Reveals Promising Preclinical Results for d3-T, a First-in-Class Women’s Testosterone Therapy, at ENDO 2025 Aviva Biopharm Inc. (Aviva Bio), a clinical-stage biopharmaceutical company developing next-generation hormone therapies for women, announced today that new preclinical data on its lead…

Read MoreAviva Biopharm Reveals Promising Preclinical Results for d3-T, a First-in-Class Women’s Testosterone Therapy, at ENDO 2025
ViiV Healthcare Expands Licensing Deal with Medicines Patent Pool to Widen Access to Long-Acting Injectable HIV Therapy

ViiV Healthcare Expands Licensing Deal with Medicines Patent Pool to Widen Access to Long-Acting Injectable HIV Therapy

ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced an update to their voluntary licensing agreement with the Medicines Patent Pool (MPP) for cabotegravir to include patents relating to its…

Read MoreViiV Healthcare Expands Licensing Deal with Medicines Patent Pool to Widen Access to Long-Acting Injectable HIV Therapy
Simulations Plus Invests in Clinical Development Technology Company Nurocor

Simulations Plus Invests in Clinical Development Technology Company Nurocor

Simulations Plus, a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced an investment of $1 million in technology company Nurocor. Founded in 2017, Nurocor offers a cloud-based software platform designed to…

Read MoreSimulations Plus Invests in Clinical Development Technology Company Nurocor
SBC Medical Group Appoints Renowned Plastic Surgery Expert Dr. Steven R. Cohen as Medical Strategy Advisor to Drive Global Expansion

SBC Medical Group Appoints Renowned Plastic Surgery Expert Dr. Steven R. Cohen as Medical Strategy Advisor to Drive Global Expansion

SBC Medical Group Appoints Renowned Plastic Surgery Expert Dr. Steven R. Cohen as Medical Strategy Advisor to Drive Global Expansion SBC Medical Group Holdings (headquarters: California, USA; CEO: Yoshiyuki Aikawa) is pleased to announce that Dr. Steven R. Cohen, a…

Read MoreSBC Medical Group Appoints Renowned Plastic Surgery Expert Dr. Steven R. Cohen as Medical Strategy Advisor to Drive Global Expansion